Results of City of Hope Clinical Trial Supports Change to Standard of Care for HIV Lymphoma

Impressive new data, to be presented during a press session at the American Society of Hematology meeting Dec. 8 at 8 a.m., indicate that HIV-associated lymphoma patients who meet standard eligibility criteria for transplants of their own stem cells respond well to the treatment, even in centers that do not have HIV-specific expertise. HIV infection has historically been viewed as reason to rule out autologous stem cell transplant - the standard of care for non-infected patients with relapsed or treatment-resistant lymphoma - due to their compromised immune system.

http://ift.tt/1I68Z90